The role of trophoblast cell damage and coagulopathy in the pregnant mice models with preeclamsia-like symptoms
The role of trophoblast cell damage and coagulopathy in the pregnant mice models with preeclamsia-like symptoms
批准号:
15591739
负责人:
SUGIMURA Motoi
金额:
$2.05万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2005
中文摘要
为了探讨胎盘绒毛间间隙高凝状态是否会诱发子痫前期样症状,我们重点研究了带负电荷的磷脂微泡(磷脂酰丝氨酸/磷脂酰胆碱PS/PC)和血管内皮生长因子(VEGF)。我们之前的报道表明,PS/PC微泡诱导宫内生长受限,胎儿和胎盘中缺乏细胞周期蛋白依赖性激酶抑制剂p57kip2的表达,VEGF_<164>的高表达在妊娠小鼠子痫前期样症状的发展中起作用。我们建立了新的子痫前期样症状动物实验模型如下,PS/PC和VEGF对子痫前期样症状的诱导提示其与子痫前期的病理生理有关。1)人工PS/PC囊泡诱导宫内生长受限,收缩压升高。血浆TAT升高和胎盘弥漫性纤维蛋白沉积表明凝血酶形成增强,舒张压显著升高可由胎盘高凝引起。2)外源性VEGF_<164>诱导胎盘循环出现子痫前期样症状和高凝,收缩压明显升高。抗vegf中和抗体抑制弥漫性纤维蛋白沉积胎盘的收缩压升高和组织学改变。这些新建立的动物模型表明,活化血小板衍生的PS/PC和滋养细胞衍生的VEGF引起的高凝状态在子痫前期样症状中起重要作用。在这些实验模型中,对子痫前期的机制有待进一步的研究。
英文摘要
In order to investigate whether the hypercoagulable state in intervillous space in placenta can induce the preeclampsia-like symptoms, we have focused on the negatively-charged phospholipid microvesicles (phosphatidylserine/phosphatidylcholine PS/PC) and vascular endothelial growth factor (VEGF). Our previous reports have shown that PS/PC microvesicles induce intrauterine growth restriction and that the lack of cyclin-dependent kinase inhibitor, p57kip2, expression in the fetus and the placenta with higher expression of VEGF_<164> plays a role in the development of preeclamsia-like symptoms in pregnant mice.Here we have established the novel animal experimental models with preeclamsia-like symptoms as follows and the induction of preeclamsia-like symptoms by PS/PC and VEGF indicates that these are related to the pathophysiology of preeclamsia.1)The artificial PS/PC vesicles induce intrauterine growth restriction with elevations of systolic blood pressure. The elevation of plasma TAT and diffuse fibrin depositions in the placentas indicate enhanced thrombin formation and the significant elevations of SBP can be induced by hypercoagulation in placenta.2)The exogenous murine VEGF_<164> induce preeclamsia-like symptoms and hypercoagulation in the placental circulation with a significant elevation of SBP. Anti-VEGF neutralized antibody suppresses the elevation of SBP and histological changes in placentas with diffuse fibrin depositions.These novel animal models established suggest that hypercoagulable state caused by PS/PC derived from activated platelet and VEGF derived from trophblast is important in preeclamsia-like symptoms. The further research on the mechanisms of preeclamsia will be required in these experimental models.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Exogenous vascular endothelial growth factor can induce preeclampsia-like symptoms in pregnant mice.
外源性血管内皮生长因子可诱发妊娠小鼠先兆子痫样症状。
DOI:
--
发表时间:
2005
期刊:
Semin Thromb Hemost. 31(3)
影响因子:
--
作者:
[Murakami Y, Kobayashi T, Omatsu K, Suzuki M, Ohashi R, Matsuura T, Sugimura M, Kanayama N.]
通讯作者:
Kanayama N.
Sensitivity to activated protein C in patients with deep vein thrombosis during early puerperium period.
产褥期早期深静脉血栓患者对活化蛋白C的敏感性分析
DOI:
--
发表时间:
2005
期刊:
Acta Obstet Gynecol Scand. 84(8)
影响因子:
--
作者:
[Ohashi R, Sugimura.M, Kawamura T, Tamura N, Kanayama N]
通讯作者:
Kanayama N
DOI:
10.1055/s-2005-872438
发表时间:
2005-06
期刊:
Seminars in thrombosis and hemostasis
影响因子:
5.7
作者:
[K. Omatsu;Takao Kobayashi;Yusuke Murakami;Mika Suzuki;R. Ohashi;M. Sugimura;N. Kanayama]
通讯作者:
K. Omatsu;Takao Kobayashi;Yusuke Murakami;Mika Suzuki;R. Ohashi;M. Sugimura;N. Kanayama
Repair of the damaged trophoblast cells through CD44-mediated signaling
-
批准号:23592416
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2011
-
负责人:SUGIMURA Motoi
-
依托单位:
Regulation of cervical ripening of the uterus through prostaglandin E2 receptor 4
-
批准号:19591893
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.41万
-
财政年份:2007
-
负责人:SUGIMURA Motoi
-
依托单位:
Functional analysis of macrophage in placental coagulation and intrauterine growth restriction
-
批准号:12671590
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.54万
-
财政年份:2000
-
负责人:SUGIMURA Motoi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
协同靶向VE-PTP/VEGF重建胶质母细胞瘤血管稳态的双靶点抑制剂开发与机制研究
-
批准号:JCZRLH202601503
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于VEGF/VEGFR信号通路探讨自拟创疡膏对慢性创面的作用机制研究
-
批准号:2026JJ80680
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:姜平
-
依托单位:
Decorin调控ADAMTS12 m6A甲基化与IL12B/VEGF免疫互作介导肥胖合并妊娠期糖尿病子代心血管疾病的作用研究
-
批准号:2026JJ81694
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:罗慧
-
依托单位:
RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
-
批准号:2026JJ80684
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚攀
-
依托单位:
金黄跌打散联合海桐皮汤通过HIF-1α/VEGF通路干预新生血管形成防治软骨损伤的机制研究
-
批准号:2026JJ81074
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:钟炜钰
-
依托单位:
基于蛋白质组学探究VEGF转染的人脐带间充质干细胞改善小鼠急性肝衰竭的机制及验证研究
-
批准号:2026JJ81849
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈海鸥
-
依托单位:
化痰通络汤调控PIEZO1/ACSL4/VEGF轴阻断线粒体机械转导增强内皮细胞铁死亡抗性促缺血性中风后血管新生的机制研究
-
批准号:2026JJ81884
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:朱新华
-
依托单位:
IGF2BP2通过m6A甲基化修饰调控VEGF-C转录促进头颈鳞癌淋巴管生成的机制研究
-
批准号:JCZRQNB202600634
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
研究川崎病患者血清中VEGF水平与冠状动脉异常的相关性
-
批准号:2026JJ82691
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:鲁涛
-
依托单位:
养精通络方调控HIF-1α/VEGF信号通路调控“氧化应激-线粒体自噬”促进薄型子宫内膜修复的机制研究
-
批准号:2026JJ82186
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:曾晶
-
依托单位: